title: [Use of new molecules in the treatment of advanced thyroid cancer].
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Galofré
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Gómez-Sáez
authors.forename: Cristina
authors.initials: C
authors.lastname: Álvarez Escola
authors.forename: Elías
authors.initials: E
authors.lastname: Álvarez García
authors.forename: Emma
authors.initials: E
authors.lastname: Anda Apiñaniz
authors.forename: Amparo
authors.initials: A
authors.lastname: Calleja
authors.forename: Sergio
authors.initials: S
authors.lastname: Donnay
authors.forename: Anna
authors.initials: A
authors.lastname: Lucas-Martin
authors.forename: Edelmiro
authors.initials: E
authors.lastname: Menéndez Torre
authors.forename: Elena
authors.initials: E
authors.lastname: Navarro González
authors.forename: Vicente
authors.initials: V
authors.lastname: Pereg
authors.forename: Begoña
authors.initials: B
authors.lastname: Pérez Corral
authors.forename: Javier
authors.initials: J
authors.lastname: Santamaría Sandi
authors.forename: Garcilaso
authors.initials: G
authors.lastname: Riesco Eizaguirre
authors.forename: Carles
authors.initials: C
authors.lastname: Zafón Llopis
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D002986:Clinical Trials as Topic; D006801:Humans; D058990:Molecular Targeted Therapy; D015337:Multicenter Studies as Topic; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology; D017410:Practice Guidelines as Topic; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D035703:Therapies, Investigational / Q000639:trends*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors